All Stories

  1. Predicting the risk of the formation of mixed anxiety and depressive disorders in women
  2. The relationship of hormones of the hypothalamic – pituitary – thyroid axis with cognitive impairment in patients with schizophrenia
  3. The impact of the hypothalamic-pituitary-thyroid axis hormone levels on suicide risk in patients with schizophrenia
  4. Hormones, oxidized proteins, and lipids in alcoholism. Duration of remission
  5. P.0601 Thyroid hormones levels in patients with schizophrenia receiving conventional and atypical antipsychotics
  6. Effects of long-term therapy with quetiapine and olanzapine on parameters of immunity and cytokine levels in patients with schizophrenia
  7. Body Fat Parameters, Glucose and Lipid Profiles, and Thyroid Hormone Levels in Schizophrenia Patients with or without Metabolic Syndrome
  8. Parameters of immunity and level of cortisol in schizophrenic patients under long-term therapy with risperidone
  9. Prediction of visceral obesity in schizophrenic patients under therapy with antipsychotics
  10. Olfaction, pain sensitivity and immunoendocrine system in substance use disorders
  11. PSYCHOMETRIC EVALUATION OF SYMPTOMS AND CLINICAL DYNAMICS OF SCHIZOPHRENIA IN DEPENDING ON CONSTITUTIONALLY-MORPHOLOGICAL TYPE OF THE PATIENTS
  12. Interferon gamma inducer in therapy of schizophrenia
  13. Association of Cytokine Production with Hormone Level and Sensory Responses during the Formation of Psychoactive Drug Addiction in Men
  14. P.1.f.004 Immunomodulating effects of classical and atypical antipsychotics
  15. 1585 – Social adaptation and immune reactivity in schizophrenia
  16. P03-264 - Dynamics of psychopathological symptomatology and cytokine levels in the process of schizophrenic patients treatment
  17. P.3.f.012 Psychoneuroimmune interactions in schizophrenia
  18. P03-84 - Immune reactivity and variants of clinical-social adaptation in schizophrenia
  19. TECHNOLOGY OF IMMUNOCORRECTION AT MENTAL DISORDERS
  20. P.3.d.01l The immunomodulatory effects of atypical neuroleptics quetiapine and amisulpride in the dynamics of 6-week treatment
  21. P.3.d.011 Immunotropic effects of atypical neuroleptics olanzapine and amisulpride
  22. Immune parameters and aminotransferase blood serum level in dynamics of atypical neuroleptics treatment of schizophrenic patients
  23. P.2.021 Effects of atypical neurolepticquetiapine on blood indices, humoral immunity and body weight in patients with schizophrenia
  24. P.2.016 Influence of atypical neuroleptic on cell apoptosis in patients with schizophrenia in the course of the therapy
  25. Stress and immunity by change of place of residence
  26. The basic variants of immune function in schizophrenia
  27. Ego defense mechanisms and immunological status